CollPlant Biotechnologies Files December 2025 6-K Report
Ticker: CLGN · Form: 6-K · Filed: Dec 31, 2025 · CIK: 1631487
Sentiment: neutral
Topics: reporting, compliance, foreign-private-issuer
TL;DR
CollPlant Biotechnologies (CLNT) filed its December 2025 6-K, standard foreign issuer report.
AI Summary
CollPlant Biotechnologies Ltd. filed a Form 6-K for the month of December 2025. This report is for a foreign private issuer and is incorporated by reference into the company's Registration Statements on Form S-8. The company's principal executive office is located in Rehovot, Israel.
Why It Matters
This filing indicates ongoing reporting compliance for CollPlant Biotechnologies Ltd., a company involved in orthopedic, prosthetic, and surgical appliances and supplies.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- CollPlant Biotechnologies Ltd. (company) — Filer of the report
- 001-38370 (company) — SEC File Number
- Form 6-K (company) — Type of filing
- Rehovot, Israel (company) — Location of principal executive office
- Form S-8 (company) — Registration statement referenced
FAQ
What type of company is CollPlant Biotechnologies Ltd. according to its SIC code?
CollPlant Biotechnologies Ltd. is classified under SIC code 3842, which pertains to Orthopedic, Prosthetic & Surgical Appliances & Supplies.
What is the filing date and period of report for this 6-K?
The filing date and period of report for this 6-K is December 31, 2025.
Where are CollPlant Biotechnologies Ltd.'s principal executive offices located?
The company's principal executive offices are located at 4 Oppenheimer St, Weizmann Science Park, Rehovot 7670104, Israel.
Does CollPlant Biotechnologies Ltd. file annual reports under Form 20-F or 40-F?
CollPlant Biotechnologies Ltd. indicates it files annual reports under Form 20-F.
What is the SEC file number for CollPlant Biotechnologies Ltd.?
The SEC file number for CollPlant Biotechnologies Ltd. is 001-38370.
Filing Stats: 302 words · 1 min read · ~1 pages · Grade level 12.6 · Accepted 2025-12-31 08:00:01
Filing Documents
- ea0271407-6k_collplant.htm (6-K) — 10KB
- 0001213900-25-126810.txt ( ) — 12KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. COLLPLANT BIOTECHNOLOGIES LTD. Date: December 31, 2025 By: /s/ Eran Rotem Name: Eran Rotem Title: Deputy CEO and Chief Financial Officer 2